Kathleen Goin

Chief Operating OfficeratPalvella Therapeutics· In proxies 2023–2025

Pay in FY2025+76% from the year before · Palvella Therapeutics stock +772.3% the same year

Kathleen Goin was paid $2.0M in FY2025 (Dec), up 76%. Palvella Therapeutics stock rose 772.3% that year.

Pay$100 in the stock at the end of FY22 → $126

Pay is from the Summary Compensation Table of each Palvella Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

PVLA
Palvella TherapeuticsPublic company · 3 yr
- Chief Operating Officer2023 – Present · 3 yrStock in role +109%

Roles come from the proxy statements of each company.

Activity

Pay
Palvella Therapeutics COO pay rose 76% to $2.0M. The stock rose 772% in FY2025 (Dec).
DEF 14AApr 30, 2026
Pay
Palvella Therapeutics COO pay fell 16% to $1.1M. The stock fell 18% in FY2024 (Dec).
DEF 14AApr 30, 2026

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?